Old Web
English
Sign In
Acemap
>
authorDetail
>
Astrid Valles-Sanchez
Astrid Valles-Sanchez
Medicine
Tolerability
Hyperlipidemia
Bioinformatics
ANGPTL3
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AAV5-based gene therapy targeting ANGPTL3 reduces hyperlipidemia and development of atherosclerosis in APOE*3-Leiden.CETP mice
2021
Atherosclerosis
V. Zancanella
Astrid Valles-Sanchez
C. Vendrell Tornero
N. Keijzer
M. Oudshoorn-Dickmann
H. Wattimury
K. van Rooijen
M. Van Veen
M. Golinska
Hans M.G. Princen
M. de Haan
G. Stokman
Ying Poi Liu
Show All
Source
Cite
Save
Citations (0)
Translation of AMT-130 Preclinical Data to Inform the Design of the First FDA-approved Human AAV Gene Therapy Clinical Trial in Adults with Early Manifest Huntington’s Disease (4531)
2020
Neurology
Ralf Reilmann
Christopher A. Ross
Claudia Testa
Samuel Frank
Melvin M. Evers
Martin de Haan
Astrid Valles-Sanchez
Pavlina Konstantinova
Sander J. H. van Deventer
Joseph J. Higgins
Show All
Source
Cite
Save
Citations (0)
The Biodistribution and Tolerability of rAAV5-miHTT after Bilateral Intra-striatal Delivery to Non-human Primates (S16.006)
2019
Neurology
Martin de Haan
Bas Blits
Lisa Spronck
Astrid Valles-Sanchez
Melvin M. Evers
Sander J. H. van Deventer
Pavlina Kostantinova
Joseph J. Higgins
Show All
Source
Cite
Save
Citations (1)
1